Literature DB >> 8483364

Facial nerve dysfunction in osteopetrosis.

J E Benecke.   

Abstract

When facial nerve dysfunction occurs in conjunction with one of the rare temporal bone dysplasias, the physician faces a therapeutic dilemma. There is no consensus in the literature regarding the management of facial paralysis or facial spasm under these circumstances. During the past 2 years, four patients were seen with forms of osteopetroses and neurotologic symptoms. A patient with malignant, recessive osteopetrosis and a patient with Engelmann's disease were surgically managed for facial paralysis and facial spasm. The outcome of the treatment is discussed as well as the available literature on this subject. A new complication of facial nerve decompression in children with osteopetrosis is described, as well as appropriate caveats in the management of facial nerve disorders in the osteopetroses.

Entities:  

Mesh:

Year:  1993        PMID: 8483364     DOI: 10.1288/00005537-199305000-00002

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  4 in total

1.  Osteopetrosis-variable otorhinolaryngological manifestations.

Authors:  A S Bais; P Sardana; M Arora
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2003-04

2.  Sclerostin Antibody-Induced Changes in Bone Mass Are Site Specific in Developing Crania.

Authors:  Amanda L Scheiber; David K Barton; Basma M Khoury; Joan C Marini; Donald L Swiderski; Michelle S Caird; Kenneth M Kozloff
Journal:  J Bone Miner Res       Date:  2019-11-07       Impact factor: 6.741

3.  Osteomyelitis of the mandible in a patient with osteopetrosis. Case report and review of the literature.

Authors:  Carlos Moreno García; María Asunción Pons García; Raúl González García; Florencio Monje Gil
Journal:  J Maxillofac Oral Surg       Date:  2011-04-20

4.  Rare osteodysplasia of the temporal bone.

Authors:  Marcos L Antunes; José R G Testa; Ricardo Frazatto; José A F Barberi; Rogério F N D Silva
Journal:  Braz J Otorhinolaryngol       Date:  2005-08-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.